Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
9.53
-0.71 (-6.93%)
At close: Nov 13, 2026, 4:00 PM EST
9.36
-0.17 (-1.78%)
After-hours: Nov 13, 2026, 7:32 PM EST
Capricor Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
231
Market Cap
554.09M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 22.27M | -2.91M | -11.55% |
| Dec 31, 2023 | 25.18M | 22.63M | 886.81% |
| Dec 31, 2022 | 2.55M | 2.31M | 941.85% |
| Dec 31, 2021 | 244.90K | -65.35K | -21.06% |
| Dec 31, 2020 | 310.25K | -694.78K | -69.13% |
| Dec 31, 2019 | 1.01M | -666.33K | -39.87% |
| Dec 31, 2018 | 1.67M | -994.98K | -37.32% |
| Dec 31, 2017 | 2.67M | -1.33M | -33.32% |
| Dec 31, 2016 | 4.00M | -1.52M | -27.53% |
| Dec 31, 2015 | 5.52M | 730.95K | 15.27% |
| Dec 31, 2014 | 4.79M | 4.28M | 851.19% |
| Dec 31, 2013 | 503.23K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | 1.35M | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Valneva SE | 163.30M |
| REGENXBIO | 153.91M |
| Zevra Therapeutics | 147.76M |
| Orchestra BioMed Holdings | 31.21M |
| Crescent Biopharma | 15.00M |
| Surrozen | 10.53M |
| Neurogene | 925.00K |
| Entera Bio | 42.00K |
CAPR News
- 1 day ago - Capricor Therapeutics price target raised to $10.50 from $7 at Roth Capital - TheFly
- 2 days ago - Opco sees Capricor shares moving to $50 on FDA approval - TheFly
- 2 days ago - Capricor Therapeutics upgraded to Buy from Hold at Jones - TheFly
- 3 days ago - Capricor Therapeutics reports Q3 EPS (73c), consensus (41c) - TheFly
- 3 days ago - Capricor Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Capricor Therapeutics Earnings release: Q3 2026 - Filings
- 3 days ago - Capricor Therapeutics Quarterly report: Q3 2026 - Filings
- 3 days ago - Capricor Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire